Recombinant allergens for skin testing

International Archives of Allergy and Immunology

Volumn 125, Issue 2, 2001, Pages 96-111

  Schmid Grendelmeier, Peter ^a   Crameri, Reto ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

Allergy; Diagnosis; Intradermal test; Recombinant allergen; Skin prick test

Indexed keywords

ALLERGEN; BEE VENOM; LATEX; RECOMBINANT DNA;

ALLERGY; DIAGNOSTIC PROCEDURE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOTHERAPY; MITE; MOULD; POLLEN; PRICK TEST; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SKIN SENSITIZATION; SKIN TEST;

ALLERGENS; ANAPHYLAXIS; ANIMALS; ETHICS, MEDICAL; FUNGI; HUMANS; INSECTS; INTRADERMAL TESTS; MAMMALS; MITES; PLANTS; POLLEN; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SKIN TESTS;

EID: 0034944436     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053803     Document Type: Review

References (157)

1. Position paper. Allergen standardization and skin tests
2. Allergy to plant-derived fresh foods in a birch- and ragweed-free area
3. The use of standardized allergen extracts
4. Future directions for allergen immunotherapy
5. The histamine content of allergen extracts
6. Immunosuppression in vitro by a metabolite of a human pathogenic fungus
7. Allergen source materials and quality control of allergenic extracts
8. The effect of time and extraction buffers on residual protein and allergen content of extracts derived from four strains of Alternaria
9. The stability of house dust mite allergens in glycerinated extracts
10. Studies of allergen extract stability: The effects of dilution and mixing
11. Factors influencing the quality of food extracts for in vitro and in vivo diagnosis
12. The batch-to-batch variation of the potency of dog- and cat-allergen-coated lancets. Evaluation by skin prick testing
13. Skin test reactivity to recombinant Aspergillus fumigatus allergen I/a in patients with cystic fibrosis
14. Antibody determination against Aspergillus fumigatus by means of the enzyme-linked immunosorbent assay. II. Physico- and immunochemical properties of the polystyrene-binding components
15. A multicenter study on skin-test reactivity of human volunteers to venom as compared with whole body Hymenoptera antigens
16. A comparative study of the allergens of cat urine, serum, saliva and pelt
17. Standardization of allergenic extracts of Aspergillus fumigatus. Liberation of IgE-binding components during cultivation
18. Allergens ofEpicoccum nigrumgrown in different media for quality source material
19. False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssinus) allergens
20. Effects of mold proteases on the biological activity of allergenic pollen extracts
21. Allergenicity of acid protease secreted by Candida albicans
22. Recombinant expression and antigenic properties of a 32-kilodalton extracellular alkaline protease, representing a possible virulence factor from Aspergillus fumigatus
23. A comparison of skin prick tests, intradermal skin tests, and RASTs in the diagnosis of cat allergy
24. Evaluation of a multiple food specific IgE antibody test compared to parental perception, allergy skin tests and RAST
25. Epidemiology and molecular basis of the involvement of Aspergillus fumigatus in allergic diseases
26. Variability of antigenicity/allergenicity in different strains of Alternaria alternata
27. Stability of cereal allergens
28. Skin prick testing with standardized extracts from three different manufacturers. A comparative randomized study
29. Automated specific IgE assay with recombinant allergens: Evaluation of the recombinant Aspergillus fumigatus allergen I in the Pharmacia Cap System
30. Recombinant allergens
31. The importance of recombinant allergens for diagnosis and therapy of IgE-mediated allergies
32. Diagnostic and therapeutic value of synthetic or recombinant allergens
33. Recombinant allergens: Diagnostic use and therapeutic perspectives
34. Recombinant allergens for diagnosis and therapy of allergic disease
35. Plant allergens and pathogenesis-related proteins. What do they have in common?
36. Towards defining the full spectrum of important house dust mite allergens
37. Allergy to mammalian proteins: At the borderline between foreign and self?
38. Molecular characterisation of mould allergens involved in respiratory complications
39. Fungal allergens
40. Structure and biology of stinging insect venom allergens
41. Genetically modified food: A danger or a benefit for atopics?
42. Cloning, production, purification and biological activity of an 18 kDa Aspergillus fumigatus allergen
43. High-frequency binding of IgE to the Der p allergen expressed in yeast
44. Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia coli
45. Diagnostic value of recombinant Aspergillus fumigatus allergen I/a for skin testing and serology
46. Skin-test reactivity and isotype-specific immune responses to recombinant Asp f 3, a major allergen of Aspergillus fumigatus
47. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy
48. 2
49. The biological function of allergens: Relevant for the induction of allergic diseases?
50. Allergens of Aspergillus fumigatus and Candida boidinii share IgE-binding epitopes
51. Age-dependent tendency to become sensitized to other classes of aeroallergens in atopic asthmatic children
52. Dominant epitopes and allergic cross-reactivity: Complex formation between a Fab fragment of a monoclonal murine IgG antibody and the major allergen from birch pollen Bet v 1
53. IgE-binding epitopes of enolases, a class of highly conserved fungal allergens
54. X-ray and NMR structure of Bet v 1, the origin of birch pollen allergy
55. Crystallization and preliminary X-ray investigation at 2.0 Å resolution of Bet v 1, a birch pollen protein causing IgE-mediated allergy
56. Probing the molecular basis of allergy. Three-dimensional structure of the bovine lipocalin allergen Bos d 2
57. Crystal structure of the allergen Equ c 1. A dimeric lipocalin with restricted IgE-reactive epitopes
58. X-ray crystal structures of birch pollen profilin and Phl p 2
59. The highly refined solution structure of the cytotoxic ribonuclease alpha-sarcin reveals the structural requirements for substrate recognition and ribonucleolytic activity
60. Component-resolved diagnosis (CRD) of type I allergy with recombinant grass and tree pollen allergens by skin testing
61. Reduced in vivo allergenicity of Bet v 1d isoform, a natural component of birch pollen
62. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis
63. Recombinant Aspergillus fumigatus allergens: From the nucleotide sequences to clinical applications
64. Automated serology with recombinant allergens. A feasibility study
65. Skin test reactivity to two recombinant Aspergillus fumigatus allergens in A. fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization
66. Selective enrichment and high throughput screening of phage surface-displayed cDNA libraries from complex allergenic systems
67. Tapping allergen repertoires by advanced cloning technologies
68. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT)
69. 2 induces specific T-cell anergy in patients allergic to bee venom
70. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: Potential use of hypoallergenic isoforms for immunotherapy
71. Clinical evaluation of genetically engineered hypoallergenic rBet v 1 derivatives
72. Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: Results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season
73. Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: Candidates for specific immunotherapy
74. Genetically engineered and synthetic allergen derivatives: Candidates for vaccination against type I allergy
75. Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen-allergic patients
76. Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: Results obtained in a French population
77. Molecular cloning and epitope analysis of the peanut allergen Ara h 3
78. Selective cloning of peanut allergens, including profilin and 2S albumins, by phage display technology
79. Recombinant mite allergens. New technologies for the management of patients with asthma
80. Non-anaphylactic combination of partially deleted fragments of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy
81. Position paper. Skin tests used in type I allergy testing
82. Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) with IgE binding and type I skin test activity
83. Sequence analysis of cDNA coding for a major house dust mite allergen, Der p 1. Homology with cysteine proteases
84. Immunological activity of recombinant Ole e 1 in patients withOlea europaea pollinosis
85. Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from timothy grass (Phleum pratense) pollen
86. Evaluation of IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, and Phl p 5) in a random sample of patients with specific IgE to Phleum pratense
87. Actin binding proteins that change extent and rate of actin monomer-polymer distribution by different mechanisms
88. Structural biology of allergens
89. Association between pollen hypersensitivity and edible vegetable allergy: A review
90. Identification of profilin as a novel pollen allergen: IgE autoreactivity in sensitized individuals
91. IgE-mediated reactions to autoantigens in allergic diseases
92. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: A quantitative IgE inhibition study with sera from different populations
93. Skin testing with recombinant allergens rBet v 1 and birch profilin, rBet v 2: Diagnostic value for birch pollen and associated allergies
94. Sequence analysis and expression of a cDNA clone encoding a 98-kDa allergen in Dermatophagoides farinae
95. Skin prick test and serological analysis with recombinant group 2 allergens of the dust mites L. destructor and T. putrescentiae
96. Recombinant allergens for diagnosis of mite allergy in children with asthma and/or rhinitis: Comparison with commercial extracts
97. Characterization of Der p 5 allergen, cDNA analysis, and IgE-mediated reactivity to the recombinant protein
98. Biological activity of recombinant Der p 2, Der p 5 and Der p 7 allergens of the house-dust mite Dermatophagoides pteronyssinus
99. In vivo biological activity of recombinant Der p II allergen of house-dust mite
100. Sensitization to Blomia tropicalis in patients with asthma and identification of allergen Blo t 5
101. Allergenic differences between the domestic mites Blomia tropicalis and Dermatophagoides pteronyssinus
102. Allergens from mites: Implications of cross-reactivity between invertebrate antigens
103. Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus
104. 2 protein
105. Crystallization and preliminary characterization of mitogillin, a ribosomal ribonuclease from Aspergillus restrictus
106. Identification of allergic bronchopulmonary aspergillosis in cystic fibrosis patients by recombinant Aspergillus fumigatus I/a-specific serology
107. Different reactivity to recombinant Aspergillus fumigatus allergen I/a in patients with atopic dermatitis or allergic asthma sensitised to Aspergillus fumigatus
108. Recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) in the diagnosis of Aspergillus-related diseases
109. Clinical testing of recombinant allergens of the mold Alternaria alternata
110. Standardization of Alternaria alternata: Extraction and quantification of Alt a 1 by using an mAb-based 2-site binding assay
111. IgE-binding proliferative responses and skin test reactivity to Cop c 1, the first recombinant allergen from the basidiomycete Coprinus comatus
112. 2
113. Allergens in bee venom. III. Identification of allergen B of bee venom as an acid phosphatase
114. Antibody responses to bee melittin (Api m 4) and hornet antigen 5 (Dol m 5) in mice treated with the dominant T-cell epitope peptides
115. 2
116. 2 from honey-bee venom is similar
117. 2
118. 2 does not affect the specific IgE, IgG4 and cytokine responses in bee sting allergy
119. Celery allergy associated with birch and mugwort pollinosis
120. IgE cross-reactivity between birch pollen, mugwort pollen and celery is due to at least three distinct cross-reacting allergens: Immunoblot investigation of the birch-mugwort-celery syndrome
121. IgE reactivity to Api g 1, a major celery allergen, in a Central European population is based on primary sensitization by Bet v 1
122. Molecular and biochemical classification of plant-derived food allergens
123. Profilins constitute a novel family of functional plant pan-allergens
124. N-terminal sequences of high molecular weight allergens from celery tuber
125. Molecular characterization of Api g 1, the major allergen of celery (Apium graveolens), and its immunological and structural relationships to a group of 17-kDa tree pollen allergens
126. Cloning of the minor allergen Api g 4 profilin from celery Apium graveolens and its cross-reactivity with birch pollen profilin Bet v 2
127. Latex allergens
128. Latex allergy in the workplace
129. Latex allergy in children
130. Cloning of the patatin-like latex allergen Hev b 7, its expression in the yeast Pichia pastoris and its immunological characterization
131. Diagnostic performance of Food and Drug Administration-cleared serologic assays for natural rubber latex-specific IgE antibody. The Multi-Center Latex Skin Testing Study Task Force
132. Latex-fruit syndrome: Frequency of cross-reacting IgE antibodies
133. Identification of aHevea brasiliensislatex manganese superoxide dismutase (Hev b 10) as a cross-reactive allergen
134. Skin prick test reactivity to recombinant latex allergens
135. 2. Ein Modell fur die Standardisierung von rekombinanten Allergenen
136. The skin prick test in the diagnosis of atopic allergy
137. Expression of the house dust mite allergen Der p 2 in the baker's yeast Saccharomyces cerevisiae
138. Purified natural and recombinant Fel d 1 and cat albumin in in vitro diagnostics for cat allergy
139. High-level expression of cockroach allergen, Bla g 4, in Pichia pastoris
140. Identification, cloning, and characterization of a major cat flea salivary allergen (Cte f 1)
141. Efficient gene transfer into human hepatocytes by baculovirus vectors
142. Brief report: Evaluation of polymerized ragweed extracts by intradermal end point titration, RAST inhibition, and parallel line bioassay
143. Discrepancies between the skin test and IgE antibody assays: Study of histamine release, complement activation in vitro, and occurrence of allergen-specific IgE
144. An assessment of the role of intradermal skin testing in the diagnosis of clinically relevant allergy to timothy grass
145. Recombinant Bet v 1, the major birch pollen allergen, induces hypersensitivity reactions equal to those induced by natural Bet v 1 in the airways of patients allergic to tree pollen
146. The safety of skin tests and the information obtained from using different methods and concentrations of allergen
147. Skin prick tests may give generalized allergic reactions in infants
148. Regulations governing the licensure of recombinant allergens and peptides
149. Antibiotic preparations contain DNA: A source of drug resistance genes
150. Different profiles in specific IgE to rBet v 1 and rBet v 2 in patients allergic to birch pollen from six countries
151. Comparison of recombinant timothy grass pollen allergens with natural extract for diagnosis of grass pollen allergy in different populations
152. Allergic bronchopulmonal aspergillosis
153. Recombinant allergens for diagnosis of allergic bronchopulmonary aspergillosis
154. Cloning, production, characterization and IgE cross-reactivity of different manganese superoxide dismutases in individuals sensitized to Aspergillus fumigatus
155. Immunologic characterization of a recombinant American cockroach (Periplaneta americana) Per a 1 (Cr-PII) allergen
156. Serological and skin-test diagnosis of birch pollen allergy with recombinant Bet v1, the major birch pollen allergen
157. Protein sequence analysis and mapping of IgE and IgG epitopes of an allergenic 98-kDa Dermatophagoides farinae paramyosin, Der f 11